Clinical Trial Update: Evaluation of Adherence to Solifenacin Treatment in Overactive Bladder Patients

View source ↗

Summary

Astellas-sponsored trial assessed adherence to solifenacin therapy in patients with overactive bladder. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Solifenacin (solifenacin)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Urinary Bladder, Overactive, Overactive Bladder | Status: COMPLETED